A Prospective Sub-Study of the Global Hypophosphatasia Registry

Clinical trial NCT05234567 · RECRUITING

Trial details

NCT number: NCT05234567
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Hypophosphatasia

Start date: 2022-08-25
Primary completion: 2028-07-18
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.